On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., a biopharmaceutical company focused on delivering therapeutic...
8 KB (684 words) - 22:18, 3 June 2024
Sepracor for $2.6B in 2010, renaming its new stand-alone subsidiary Sunovion. Under Sunovion management, Sumitomo Dainippon Pharma was able to successfully...
10 KB (777 words) - 04:16, 10 June 2024
medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals (which was subsequently merged into Sumitomo Pharma) using...
10 KB (815 words) - 14:07, 11 January 2024
reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and...
8 KB (638 words) - 18:19, 15 January 2024
Novartis licensed its U.S. commercial rights for Arcapta Neohaler to Sunovion Pharmaceuticals. "Arcapta Neohaler (indacaterol) inhalation powder Initial...
7 KB (411 words) - 20:05, 20 December 2023
its U.S. commercial rights for Seebri Neohaler and Utibron Neohaler to Sunovion Pharmaceuticals. "Product monograph brand safety updates". Health Canada...
4 KB (210 words) - 04:40, 3 April 2024
1847– ) Strides (1990– ) Stryker (1941– ) Sumitomo (2005– ) Sun (1983– ) Sunovion (formerly Sepracor) (1984– ) Sutro (2003– ) Swedish Orphan Biovitrum (2001–...
34 KB (2,162 words) - 07:29, 3 August 2024
PMID 35047111. "Sunovion: creating therapies to help transform people's lives". www.sunovion.com. Retrieved 4 June 2022. "Sunovion and PsychoGenics Announce...
32 KB (2,036 words) - 11:13, 25 February 2024
Wyeth Lurasidone Benzisothiazole Atypical Latuda 2010 Sumitomo Dainippon/Sunovion Melperone Butyrophenone Disputed Buronil 1967 Lundbeck Mesoridazine...
207 KB (18,196 words) - 04:47, 20 July 2024
Liming Shao, et al. WO2007081542 (Sunovion Pharmaceuticals Inc). Liming Shao & Jianguo Ma, WO2010091268 (Sunovion Pharmaceuticals Inc). Heike Radeke...
128 KB (15,244 words) - 05:38, 25 July 2024
than $27,000 from PACs of pharmaceutical companies, including Astellas, Sunovion, Takeda, Horizon, Eli Lilly, Abbvie, Alexion and Lundbeck ... According...
147 KB (12,713 words) - 03:29, 2 August 2024
Lundbeck Myriad Genetics Neurocrine Biosciences Otsuka Pharmaceutical Pfizer Sunovion Takeda Pharmaceutical Company Donors to the foundation in 2019 include...
30 KB (2,917 words) - 00:28, 3 July 2024
ajp.161.6.1113. PMID 15169702. "Latuda Prescribing Information" (PDF). Sunovion Pharmaceuticals. Archived (PDF) from the original on 12 July 2018. Retrieved...
61 KB (5,109 words) - 09:18, 28 July 2024
& Co., Novartis, Novo Nordisk, Otsuka Pharmaceutical, Pfizer, Sanofi, Sunovion, Takeda Pharmaceutical Company, Teva Pharmaceutical Company and UCB. SMARxT...
15 KB (1,212 words) - 00:33, 3 August 2024
but was marketed only under the first name. In the US it is marketed by Sunovion (formerly Sepracor) and was approved in November 2013. Studies for the...
14 KB (1,248 words) - 17:56, 15 March 2024
changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire...
4 KB (435 words) - 00:54, 4 June 2024
Biosciences NeuroStar Northrop Grumman Novo Nordisk Otsuka Pharmaceutical Pfizer Sunovion Takeda Pharmaceutical Company Teva Pharmaceuticals The 2017 annual report...
44 KB (4,058 words) - 21:13, 22 June 2024
Schizophrenia with Dr. Stephen M. Stahl, University of Bristol" (PDF). Sunovion Pharmaceuticals Europe Ltd. 2015. "Honorary Doctorate Title presented to...
12 KB (1,154 words) - 20:39, 29 May 2024
healthcare investigators to collect medical quality data for research. In 2017, Sunovion used Embrace in a phase 4 clinical study of Aptiom, a drug meant to reduce...
18 KB (1,871 words) - 10:21, 23 July 2023
distribute it as Zebinix or Exalief in Europe. In America it is marketed by Sunovion under the name Aptiom. Its use in epilepsy treatment in children is under...
8 KB (816 words) - 11:09, 19 February 2024
Roche Ropack Pharma Solutions Sanofi Santen Pharmaceutical Servier Sobi Sunovion Takeda Pharmaceutical Company Theratechnologies Valeo Pharma Vantage Biotrials...
12 KB (919 words) - 18:27, 19 February 2024
National Brain Disorders Prize, University of British Columbia 2020 Sumitomo/Sunovion Brain Health Clinical Research Award, CINP 2020 Colvin Prize in Mood Disorders...
24 KB (2,030 words) - 03:49, 31 May 2024
Sanofi Aventis Sanofi Pasteur Seagen Servier Shire Sobi Stallergenes Greer Sunovion Syneos Health Takeda Pharmaceutical Company TBWA Worldwide Teva Pharmaceuticals...
10 KB (798 words) - 17:17, 19 February 2024
CFID include AbbVie, BD, BioMérieux, Gilead Sciences, KPMG, Merck, and Sunovion. AMMI Canada's principal event is the AMMI Canada-CACMID Annual Conference...
14 KB (1,149 words) - 23:05, 22 July 2024
2022 International College of Neuropsychopharmacology (CINP) - Sumimoto/Sunovion Brain Health Basic Research Award 2020 McGill Principal's prize for public...
14 KB (1,363 words) - 20:42, 1 May 2024
(2024) Knight of the Order of Merit, The Chancery of Orders (2023) Sumitomo/Sunovion Prize, International College of Neuropsychopharmacology (2023) Doctor Honoris...
32 KB (3,012 words) - 07:15, 28 June 2024
cycloalkylamines as monoamine reuptake inhibitors", published 2017-06-28, assigned to Sunovion Pharmaceuticals Inc. Provencher BA, Eshleman AJ, Johnson RA, Shi X, Kryatova...
35 KB (4,041 words) - 09:52, 21 July 2024
Dainippon Sumitomo Pharma purchased Sepracor, which currently operates as Sunovion, Inc. Biomembrane-mediated cell adhesion and transport: Quinn later returned...
14 KB (1,685 words) - 11:57, 27 December 2023
International College of Neuropsychopharmacology with the CINP Sumitomo/Sunovion Brain Health Clinical Research Award and has been appointed as a member...
8 KB (868 words) - 18:23, 30 July 2024
Executive Medical Director and Head of the Medical Science Liaison Group at Sunovion Pharmaceuticals, Inc. in Marlborough, Massachusetts. In 2013 Herman took...
17 KB (2,224 words) - 19:34, 15 December 2023